Literature DB >> 14685535

[Assessing and treating pain in the newborn]

R Guinsburg1.   

Abstract

OBJECTIVES: To update information about available neonatal pain assessment and pain relief methods.
METHOD: Medical literature review of the past 10 years, including textbooks, general reviews, systematic reviews, prospective, randomized controlled studies, retrospective works and case studies. Literature was reviewed based on the author clinical and scientific experience regarding pain evaluation and treatment.
RESULTS: Lack of verbal expression of pain is one of the major impediments to adequate pain relief in the neonatal period. Nowadays, several valid pain assessment tools are available, including the analysis of the neonate facial features and multidimensional tools, as NIPS, CRIES, and PIPP. Non-pharmacological pain relief can be achieved by non-nutritive suction and suction of dextrose water. Neonatal analgesia, in general, includes de the use of paracetamol, opioids and local anesthetics. Opioids remain the main resource for acute pain treatment in the neonatal intensive care unit. Sedatives are important agents to decrease patient activity and restlessness, but they do not relieve pain.
CONCLUSION: Based on medical, ethical, and humanitarian grounds, neonatal pain should be considered and treated.

Entities:  

Year:  1999        PMID: 14685535     DOI: 10.2223/jped.290

Source DB:  PubMed          Journal:  J Pediatr (Rio J)        ISSN: 0021-7557            Impact factor:   2.197


  2 in total

1.  Translation and cultural adaptation of the Brazilian Portuguese version of the Behavioral Pain Scale.

Authors:  Márcia Carla Morete; Sarah Camargo Mofatto; Camila Alves Pereira; Ana Paula Silva; Maria Tereza Odierna
Journal:  Rev Bras Ter Intensiva       Date:  2014 Oct-Dec

2.  Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit.

Authors:  Verônica Cheles Vieira; Renart Santos Costa; Raquel Cristina Gomes Lima; Daiane Borges Queiroz; Danielle Souto de Medeiros
Journal:  Rev Bras Ter Intensiva       Date:  2021 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.